4 Results for "

GL-3 levels

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "GL-3 levels" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-16743
CAS No.: 1401090-53-6
Synonyms: VenGLustat; SAR402671; GZ402671
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743A
CAS No.: 1629063-78-0
Synonyms: VenGLustat (L-Malic acid); SAR402671 (L-Malic acid); GZ402671 (L-Malic acid)
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743B
CAS No.: 1629063-80-4
Synonyms: VenGLustat succinate; SAR402671 succinate; GZ402671 succinate
Research Areas:  

Neurological Disease

Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
Cat. No.: HY-16743C
CAS No.: 1629063-79-1
Synonyms: VenGLustat hydrochloride; SAR402671 hydrochloride; GZ402671 hydrochloride
Research Areas:  

Metabolic Disease

Ibiglustat hydrochloride is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat hydrochloride can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...